Medtronic pitches broader platform growth as EU neuromodulation clearance boosts multi-franchise outlook
Medtronic’s near-term narrative is shifting from ‘single-product cycles’ to broader platform growth, with neuromodulation, robotics, AI-enabled workflows, and partnership economics surfacing as the week’s most actionable signals.